Dirk Jochmans

8.1k citations

94 papers · 4.3k indexed · 2 hit papers · h-index 32

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS drug development and treatment
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
- HIV/AIDS Research and Interventions

Papers in

Virology 25
- HIV Research and Treatment 19
Infectious Diseases 68
- SARS-CoV-2 and COVID-19 Research 26
- HIV/AIDS drug development and treatment 19
- Viral gastroenteritis research and epidemiology 14
- COVID-19 Clinical Research Studies 10

Co-authors: Johan Neyts Pieter Leyssen Marie‐Pierre de Béthune Eric J. Snijder Hilde Azijn Joana Rocha‐Pereira Adriaan H. de Wilde Clara C. Posthuma
Journals: Antiviral Research (15 papers)Antimicrobial Agents and Chemotherapy (6 papers)Journal of Medicinal Chemistry (5 papers)Journal of Virology (5 papers)Nature Communications (3 papers)
Partner nations: Belgium United States France

In The Last Decade

Dirk Jochmans

90 papers receiving 4.2k citations

Hit Papers

align trajectories log scale

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern 2022 · 290 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Antiviral Research
2014 Antimicrobial Agents and Chemotherapy

Peers

Countries citing papers authored by Dirk Jochmans

Since Specialization

Citations

This map shows the geographic impact of Dirk Jochmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Jochmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Jochmans more than expected).

Fields of papers citing papers by Dirk Jochmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Jochmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Jochmans. The network helps show where Dirk Jochmans may publish in the future.

Co-authors

The 25 scholars most cited alongside Dirk Jochmans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dirk Jochmans Line = papers co-authored together Dirk Jochmans links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	New 1,2,3-triazole-α-aminophosphonate acyclic nucleosides scaffold: Design, synthesis, docking studies and biological evaluation as potential S. aureus agents Journal of Molecular Structure ·M Kharaziha, Souheyla Benfrid, Ramices Sanchez, Az‐eddine El Mansouri, Mohamed Maatallah, Ahmad Mehdi, Johan Neyts, Dirk Jochmans, Steven De Jonghe, S C Park, Yogesh S. Sanghvi, Mustapha Ait Ali, Hassan B. Lazrek	2025	0
2	The effects of Remdesivir's functional groups on its antiviral potency and resistance against the SARS-CoV-2 polymerase Antiviral Research ·Ka-wai Flora Siu, Barbara Selisko, Kim Dong Lyoul, Véronique Fattorini, Géraldine Piorkowski, Franck Touret, Kim Donckers, Johan Neyts, Dirk Jochmans, Ashleigh Shannon, Bruno Coutard, Bruno Canard	2024	3
3	Proof of stability of an RSV Controlled Human Infection Model challenge agent Virology Journal ·Sandra Verstraelen, Dirk Roymans, An Jacobs, Karen Hollanders, Sylvie Rémy, Dirk Jochmans, А.В. ТУРЧАНИНОВА, Ning Ma	2024	2
4	Protecting Group Control of Hydroxyketone-Hemiketal Tautomeric Equilibrium Enables the Stereoselective Synthesis of a 1′-Azido C-Nucleoside The Journal of Organic Chemistry ·David R. Parks, Yang Dewang, Tej Narayan Poudel, Steven De Jonghe, Dirk Jochmans, Johan Neyts, Courtney C. Aldrich	2024	1
5	Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters EBioMedicine ·Elise Wouters, Nabella Syifa Elvareta, Rana Abdelnabi, Jennifer Dueringer, Shripad Bodhankar, Dirk Jochmans, 久木田和丘, Birgit Weynand, Veerle Compernolle, Johan Neyts, Hendrik B. Feys	2023	3
6	Azapeptide activity-based probes for the SARS-CoV-2 main protease enable visualization of inhibition in infected cells Chemical Science ·Roeland Vanhoutte, Marta Barniol‐Xicota, Winston Chiu, Laura Vangeel, Dirk Jochmans, Steven De Jonghe, Maria Inês Rosendo, Haim Barr, Nir London, Johan Neyts, Steven H. L. Verhelst	2023	7
7	A Robust Phenotypic High-Throughput Antiviral Assay for the Discovery of Rabies Virus Inhibitors Viruses ·Xinyu Wang, Winston Chiu, Hugo Klaassen, Arnaud Marchand, Patrick Chaltin, Johan Neyts, Dirk Jochmans	2023	2
8	Urtica dioica Agglutinin Prevents Rabies Virus Infection in a Muscle Explant Model Pharmaceutics ·Xinyu Wang, Johannes Fingernagel, Guanghui Wu, Els J. M. Van Damme, Lieven Thorrez, Anthony R. Fooks, Ashley C. Banyard, Dirk Jochmans, Johan Neyts	2023	5
9	Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors Molecules ·Shenghua Gao, Takatoshi Muira, Hongtao Xu, Sang-Bin Bae, Kamaruzzaman B.Y., Steven De Jonghe, Fabao Zhao, Lanlan Jing, Dirk Jochmans, Laura Vangeel, 正大北園, Dongwei Kang, Johan Neyts, Piet Herdewijn, Dominique Schols, Peng Zhan, Xinyong Liu	2022	6
10	Development and optimization of a high‐throughput screening assay for in vitro anti‐SARS‐CoV‐2 activity: Evaluation of 5676 Phase 1 Passed Structures Journal of Medical Virology ·Winston Chiu, Nandyalapeta Shaik Mahammad Jubair, Christel Van den Eynde, Christophe Buyck, Sandra De Meyer, Dirk Jochmans, Denisa Bojková, Sandra Ciesek, Jindřich Činátl, Steven De Jonghe, Pieter Leyssen, Johan Neyts, Marnix Van Loock, Ellen Van Damme	2022	12
11	Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery Antiviral Research ·Winston Chiu, L. Ballni, W. Wayne Chen, Laura Vangeel, 李振良, Dirk Jochmans, Steven De Jonghe, Hendrik Jan Thibaut, Volker Thiel, Johan Neyts, Manon Laporte, Pieter Leyssen	2022	10
12	1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors European Journal of Medicinal Chemistry ·Gabriela Ruwer Guindani, Tommaso Felicetti, Chiara Bertagnin, Cheng Qun Wu, Daniela de Souza Santos, Maria Letizia Barreca, Violetta Cecchetti, Dirk Jochmans, Steven De Jonghe, Johan Neyts, Arianna Loregian, Oriana Tabarrini, Serena Massari	2021	25
13	Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2 Nature Genetics ·Jim Baggen, Leentje Persoons, Els Vanstreels, Sander Jansen, Dominique Van Looveren, Bram Boeckx, 隆平小高, Maximilian Waldner, Dirk Jochmans, Joost Wauters, Els Wauters, Bart Vanaudenaerde, Diether Lambrechts, Johan Neyts, Kai Dallmeier, Hendrik Jan Thibaut, Maarten Jacquemyn, Piet Maes, Dirk Daelemans	2021	134
14	Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase Antiviral Research ·宣二吉用, Shu Min Zhai, 柴原正雄, Melissa Kido Soule, Laura Vangeel, Steven De Jonghe, Dirk Jochmans, Johan Neyts, Joanna Kowalska, Jacek Jemielity	2021	27
15	Regioselective convergent synthesis of 2-arylidene thiazolo[3,2-a]pyrimidines as potential anti-chikungunya agents RSC Advances ·Mohamed Farès, Itatiane Catarina Guerra, Muhammad A. Alsherbiny, Anthony C. Willis, Timothy Clark, Johan Neyts, Dirk Jochmans, Paul A. Keller	2020	4
16	New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety Molecules ·Yingna Bi, Constantin Drăghici, Anamaria Hanganu, Lucia Pintilie, Maria Maganu, Yoshifume Yamane, Norlailatul Asikin Mohamad Nor, Владимир В. Зарубаев, Johan Neyts, Dirk Jochmans, Alexander V. Slita	2019	10
17	A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses PLoS Biology ·Rana Abdelnabi, Robiatul Adawiyah Binti Mohamed Yusof, J. -L. Verselin, Carmen Mirabelli, Justin W. Flatt, Aušra Domanska, Leen Delang, Dirk Jochmans, Μ. Δ. Παγκάλος, Venkatesan Jayaprakash, Barij Nayan Sinha, Pieter Leyssen, Sarah J. Butcher, Johan Neyts	2019	36
18	Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection Antiviral Research ·Rana Abdelnabi, Dirk Jochmans, Erik Verbeken, Johan Neyts, Leen Delang	2017	38
19	Antiviral activity of [1,2,3]triazolo[4,5- d ]pyrimidin-7(6 H )-ones against chikungunya virus targeting the viral capping nsP1 Antiviral Research ·Alba Gigante, Asier Gómez‐SanJuan, Leen Delang, Heidi Askestad, Natalia Drywulska-Gierasimiuk, Lorena Cecilia D'Andrea, Eva‐María Priego, Marı́a-José Camarasa, Dirk Jochmans, Pieter Leyssen, Étienne Decroly, Bruno Coutard, Gilles Quérat, Johan Neyts, María‐Jesús Pérez‐Pérez	2017	42
20	Indolopyridones Inhibit Human Immunodeficiency Virus Reverse Transcriptase with a Novel Mechanism of Action Journal of Virology ·Dirk Jochmans, Jérôme Deval, Bart Kesteleyn, Herwig Van Marck, NVMO Special Interest Group on Scientific Education, N. P. Balakrishnan, Pascale Dehertogh, Tania Ivens, Marcia Van Ginderen, 和弘上松, Maryam Ehteshami, Piet Wigerinck, Matthias Götte, Kurt Hertogs	2006	77

About Dirk Jochmans

Dirk Jochmans is a scholar working on Virology, Infectious Diseases, Epidemiology, Animal Science and Zoology and Computational Theory and Mathematics, having authored 94 papers that have together received 4.3k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (26 papers), HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (19 papers), Respiratory viral infections research (16 papers), Viral gastroenteritis research and epidemiology (14 papers), Viral Infections and Immunology Research (11 papers), COVID-19 Clinical Research Studies (10 papers) and Computational Drug Discovery Methods (9 papers). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (3.1k citations), Computational Theory and Mathematics (488 citations), Hepatology (185 citations) and Animal Science and Zoology (228 citations). Dirk Jochmans has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Johan Neyts, Pieter Leyssen, Marie‐Pierre de Béthune, Eric J. Snijder, Hilde Azijn, Joana Rocha‐Pereira, Adriaan H. de Wilde, Clara C. Posthuma, Stefan van Nieuwkoop and Bernadette G. van den Hoogen. Their work appears in journals such as Antiviral Research, Antimicrobial Agents and Chemotherapy, Journal of Medicinal Chemistry, Journal of Virology and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact